Treatment of Androgenic Alopecia in Males

Completed · Not applicable

Conditions studied: Androgenetic Alopecia, Hair Loss, Male Pattern Baldness

In brief

The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks compared to baseline measurements.

Key facts

Study ID

NCT00947219

Run by

Lexington International, LLC

People needed

79

Starts

2009-07-01

Expected to finish

2010-08-01

Last updated by the study team

2013-01-31

Who can join

Age: 25 and older, up to 60. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of androgenetic alopecia
• Fitzpatrick Skin Types I-IV
• Norwood-Hamilton IIa to V
• Active hair loss within last 12 months

You may not qualify if…

• Photosensitivity to laser light
• Malignancy in the target area

Where it is running

• Abe Marcadis, M.D. — West Palm Beach, Florida, United States
• David Goldberg, M.D. — Hackensack, New Jersey, United States
• Zoe Draelos, M.D. — High Point, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.